tirzepatide vs semaglutide weight loss study outperformed weight-loss drug results in real world patients, shows tirzepatide vs semaglutide weight loss

Treatment depends on the underlying cause and typically involves specialist endocrinology care

Nausea, digestive changes, and other side effects are common with GLP-1s

In a prospective real-world cohort of 194 adults with type 2 diabetes initiating semaglutide or dulaglutide, only 49% achieved 5% weight loss by 12 months meaning that just under half of treated patients did not meet the threshold conventionally defined as clinically meaningful (Vozza et al., 2025)

Normalizacji rytmu dobowego stabilizuje wydzielanie melatoniny, poprawiajc jako snu i regeneracj nocn

Never change insulin dosing without medical guidance